Saileta

#drugdeveloper

[NEJM @NEJM]

Clinical Implications of Basic Research by Flora Peyvandi, MD, PhD: Reengineering Coagulation with a Bispecific Antibody https://t.co/QPYvF4rPGL

#Hematology #Genetics

[Saileta @Saileta1]

@adamfeuerstein @A_May_MD worth keeping in mind that melanoma is particularly responsive to IO, so other tumors may be a higher bar.

[Saileta @Saileta1]

I just subscribed to Vinay Prasad's Observations and Thoughts https://t.co/7JOgZcLcfg

[Saileta @Saileta1]

CDC director almost admits their policy has failed, by @VPrasadMDMPH https://t.co/pPVSmlywX2

[Saileta @Saileta1]

Leading breeder of beagles for research slammed by animal welfare inspectors https://t.co/6NiVRktzwV

[American Association of Pharmaceutical Scientists @AAPSComms]

"Our work is not yet done," said Tapan Das, Ph.D., FAAPS. AAPS scientists are leading, innovating and saving lives. Thank you to the AAPS members and partners for your incredible work during #COVID19 and beyond.
https://t.co/ht9nvJ41SL

[Saileta @Saileta1]

Have you listened to Get Curious yet? Check it out here: https://t.co/RifeQYRElr

[Saileta @Saileta1]

https://t.co/QeHH2nw3PJ

[Saileta @Saileta1]

i am getting kicked out of the #Acela because i was not wearing a mask while drinking! how can I? @Amtrak can you train your staff better? extremely rude staff.

[Saileta @Saileta1]

#science always wins! https://t.co/YJxYAToFqf

[Saileta @Saileta1]

What do these 2 tweets have in common?, by @VPrasadMDMPH https://t.co/KnCC96ciTO

[Saileta @Saileta1]

New #DrugDevelopment (#FDA) #Guidelines- part 2/2

The sponsor does not need to determine the phase II or III dose/s. Just pick a dose post phase III and market it.

Ignore the #FDAadcom

Sell the drug as an innovation for 56K. #aducanumab Make #billions for next 20yrs

[Saileta @Saileta1]

New #DrugDevelopment (#FDA) #Guidelines- part 1/2

#Post-hoc analysis of #failed Phase III/#pivotal studies allowed! #aducanumab

Pharmacodynamic #biomarkers with no link to clinically approvable #efficacy endpoints can be used together with a failed phase III to get #approval.

[arnab mukherjee @arnab_mukh3rjee]

Postdoc positions are available in my lab to develop noninvasive molecular technologies for looking at cell function inside the brain and gut. If interested, please drop me an email ([email protected]).

[Tina Morris @Schultheiss1]

Registration is now open for the biggest PharmSci360, yet! Join us virtually first and then live in Philly this October.

[Saileta @Saileta1]

@sciencescanner @VPrasadMDMPH I am not sure if we can bring in politics here. IMHO #FDA screwed this up-serious lack of #science #truepatientcare

[Saileta @Saileta1]

@timrpeterson @adamfeuerstein @damiangarde It’s definitely an unmet need😂😂😂

[Saileta @Saileta1]

@adamfeuerstein @damiangarde Sad indeed!

[Saileta @Saileta1]

@oncology_bg @matthewherper well said!!!

[Stephanie Graff, MD, FACP, FASCO @DrSGraff]

Discussants’ main conclusions #ASCO21 /10